Postoperative Levonorgestrel-Releasing Intrauterine System Insertion After Gonadotropin-Releasing Hormone Agonist Treatment for Preventing Endometriotic Cyst Recurrence: A Prospective Observational Study
Restricted accessResearch articleFirst published online January, 2018
Postoperative Levonorgestrel-Releasing Intrauterine System Insertion After Gonadotropin-Releasing Hormone Agonist Treatment for Preventing Endometriotic Cyst Recurrence: A Prospective Observational Study
The aim of this study was to evaluate the effectiveness of postoperative levonorgestrel-releasing intrauterine system (LNG-IUS) insertion after gonadotropin-releasing hormone agonist (GnRH-a) treatment for preventing endometriotic cyst recurrence.
Study Design:
The LNG-IUS was applied to 28 women who had undergone surgery for endometriosis followed by 6 cycles of GnRH-a treatment. Clinical characteristics, endometriosis recurrence, and adverse effects were analyzed. Student t test was performed for analysis.
Results:
Before surgery, 20 (71.4%) patients had dysmenorrhea, and the mean pain score (visual analog scale [VAS]) was 4.26. The numbers of women diagnosed with stage III endometriosis and stage IV endometriosis were 15 (53.6%) and 13 (46.4%), respectively, according to the revised American Fertility Society scoring system. The mean cancer antigen 125 levels and VAS scores were significantly lower after treatment than before treatment (11.61 vs 75.66 U/mL, P < .0001 and 0.50 vs 4.26 U/mL, P < .0001, respectively). Of the 28 patients, 13 (46.4%) simultaneously had adenomyosis, and 2 (7.1%) underwent LNG-IUS removal because of unresolved vaginal bleeding and dysmenorrhea. Recurrence was noted in 2 (7.1%) women.
Conclusion:
Postoperative LNG-IUS insertion after GnRH-a treatment is an effective approach for preventing endometriotic cyst recurrence, especially in women who do not desire to conceive.
FauconnierAChapronC. Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications. Hum Reprod Update. 2005;11(6):595–606.
2.
WinkelCA. Evaluation and management of women with endometriosis. Obstet Gynecol. 2003;102(2):397–408.
3.
GarryR. The effectiveness of laparoscopic excision of endometriosis. Curr Opin Obstet Gynecol. 2004;16(4):299–303.
4.
GuoSW. Recurrence of endometriosis and its control. Hum Reprod Update. 2009;15(4):441–461.
5.
Bayoglu TekinYDilbazBAltinbasSKDilbazS. Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue. Fertil Steril. 2011;95(2):492–496.
6.
TakamuraMKogaKOsugaY. Post-operative oral contraceptive use reduces the risk of ovarian endometrioma recurrence after laparoscopic excision. Hum Reprod. 2009;24(12):3042–3048.
7.
LoverroGCarrieroCRossiACPutignanoGNicolardiVSelvaggiL. A randomized study comparing triptorelin or expectant management following conservative laparoscopic surgery for symptomatic stage III-IV endometriosis. Eur J Obstet Gynecol Reprod Biol. 2008;136(2):194–198.
8.
SestiFPietropolliACapozzoloT. Hormonal suppression treatment or dietary therapy versus placebo in the control of painful symptoms after conservative surgery for endometriosis stage III-IV. A randomized comparative trial. Fertil Steril. 2007;88(6):1541–1547.
9.
LeeDYBaeDSYoonBKChoiD. Post-operative cyclic oral contraceptive use after gonadotrophin-releasing hormone agonist treatment effectively prevents endometrioma recurrence. Hum Reprod. 2010;25(12):3050–3054.
10.
ParkHJKooYAYoonBKChoiD. Postoperative long-term maintenance therapy with oral contraceptives after gonadotropin-releasing hormone analog treatment in women with ovarian endometrioma. J Minim Invasive Gynecol. 2009;16(1):34–39.
11.
LeeJYParkSMKoYJSongYS. Necessity of education for oral contraceptive use in Korea: results from the fourth Korean national health and nutrition examination survey 2007-2009. Gynecol Obstet Invest. 2013;76(1):44–50.
12.
WiebeERHendersonAChoiJTroutonK. Ethnic Korean women’s perceptions about birth control. Contraception. 2006;73(6):623–627.
13.
BrownJFarquharC. Endometriosis: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2014;10(3):CD009590.
14.
MorelliMSacchinelliAVenturellaRMocciaroRZulloF. Postoperative administration of dienogest plus estradiol valerate versus levonorgestrel-releasing intrauterine device for prevention of pain relapse and disease recurrence in endometriosis patients. J Obstet Gynaecol Res. 2013;39(5):985–990.
15.
ChoSJungJALeeY. Postoperative levonorgestrel-releasing intrauterine system versus oral contraceptives after gonadotropin-releasing hormone agonist treatment for preventing endometrioma recurrence. Acta Obstet Gynecol Scand. 2014;93(1):38–44.
16.
ExacoustosCZupiECarusottiC. Staging of pelvic endometriosis: role of sonographic appearance in determining extension of disease and modulating surgical approach. J Am Assoc Gynecol Laparosc. 2003;10(3):378–382.
17.
CallenP.Ultrasonography in Obstetrics and Gynecology. 5th edition; Philadelphia, PA: Saunders, 2008:928.
18.
KogaKTakamuraMFujiiTOsugaY. Prevention of the recurrence of symptom and lesions after conservative surgery for endometriosis. Fertil Steril. 2015;104(4):793–801.
19.
VignaliMBianchiSCandianiMSpadacciniGOggioniGBusaccaM. Surgical treatment of deep endometriosis and risk of recurrence. J Minim Invasive Gynecol. 2005;12(6):508–513.
20.
JinushiMArakawaAMatsumotoT. Histopathologic analysis of intestinal endometriosis after laparoscopic low anterior resection. J Minim Invasive Gynecol. 2011;18(1):48–53.
21.
BullettiCDeZieglerDStefanettiMCincinelliEPelosiEFlamigniC. Endometriosis: absence of recurrence in patients after endometrial ablation. Hum Reprod. 2001;16(12):2676–2679.
22.
GoumenouAGChowCTaylorAMagosA. Endometriosis arising during estrogen and testosterone treatment 17 years after abdominal hysterectomy: a case report. Maturitas. 2003;46(3):239–241.
23.
VercelliniPSomiglianaEViganoPAbbiatiABarbaraGFedeleL. ‘Blood On The Tracks’ from corpora lutea to endometriomas. BJOG. 2009;116(3):366–371.
24.
DiVastaADFeldmanHASadler GallagherJ. Hormonal add-back therapy for females treated with gonadotropin-releasing hormone agonist for endometriosis: a randomized controlled trial. Obstet Gynecol. 2015;126(3):617–627.
25.
VercelliniPSomiglianaEDaguatiRViganoPMeroniFCrosignaniPG. Postoperative oral contraceptive exposure and risk of endometrioma recurrence. Am J Obstet Gynecol. 2008;198(5):504.e501–504.e505.
26.
OuchiNAkiraSMineKIchikawaMTakeshitaT. Recurrence of ovarian endometrioma after laparoscopic excision: Risk factors and prevention. J Obstet Gynaecol Res. 2014;40(1):230–236.
27.
PerelloMFMartinez-ZamoraMATorresXMunrosJBalasch CortinaJCarmonaF. Endometriotic pain is associated with adenomyosis but not with the compartments affected by deep infiltrating endometriosis. Gynecol Obstet Invest. 2017;82(3):240–246.
28.
PettaCAFerrianiRAAbraoMS. A 3-year follow-up of women with endometriosis and pelvic pain users of the levonorgestrel-releasing intrauterine system. Eur J Obstet Gynecol Reprod Biol. 2009;143(2):128–129.
29.
KriplaniASinghBMLalSAgarwalN. Efficacy, acceptability and side effects of the levonorgestrel intrauterine system for menorrhagia. Int J Gynaecol Obstet. 2007;97(3):190–194.
